New drugs in prostate cancer

The standard primary treatment for advanced prostate cancer has been hormonal therapy since the 1940s. However, prostate cancer inevitably progresses to castration-resistant prostate cancer (CRPC) after a median duration of 18 months of androgen deprivation therapy. In patients with CRPC, docetaxel...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Prostate Int
Main Authors: Yoo, Sangjun, Choi, Se Young, You, Dalsan, Kim, Choung-Soo
Formato: Artigo
Idioma:Inglês
Publicado em: Asian Pacific Prostate Society 2016
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4916061/
https://ncbi.nlm.nih.gov/pubmed/27358841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.prnil.2016.05.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados